Product NDC: | 0004-0261 |
Proprietary Name: | CellCept |
Non Proprietary Name: | Mycophenolate Mofetil |
Active Ingredient(s): | 200 mg/mL & nbsp; Mycophenolate Mofetil |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0004-0261 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050759 |
Marketing Category: | NDA |
Start Marketing Date: | 19980812 |
Package NDC: | 0004-0261-29 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) > 225 mL in 1 BOTTLE, PLASTIC |
NDC Code | 0004-0261-29 |
Proprietary Name | CellCept |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) > 225 mL in 1 BOTTLE, PLASTIC |
Product NDC | 0004-0261 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mycophenolate Mofetil |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 19980812 |
Marketing Category Name | NDA |
Labeler Name | Genentech, Inc. |
Substance Name | MYCOPHENOLATE MOFETIL |
Strength Number | 200 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |